23804 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
18:34 UTC
|
U
Unity Software
|
◎ Target | James Callahan not yet tracked | Overweight | $45.00→ $55.00+22.2% |
|
Aug 07
18:34 UTC
|
TWLO
Twilio
|
◎ Target | James Fish ★★★★★ #102 | Neutral | $192.00→ $247.00+28.6% |
|
Aug 07
18:34 UTC
|
SION
Sionna Therapeutics
|
◎ Target | Yatin Suneja ★★★☆☆ #1773 | Buy | $50.00→ $60.00+20.0% |
|
Aug 07
18:34 UTC
|
RKT
Rocket Companies
|
◎ Target | Daniel Kurnos ★☆☆☆☆ #2940 | Buy | $21.00→ $19.00-9.5% |
|
Aug 07
18:34 UTC
|
PFE
Pfizer
|
◎ Target | Vamil Divan ★★★★☆ #374 | Buy | $35.00→ $31.00-11.4% |
|
Aug 07
18:34 UTC
|
PENN
PENN Entertainment
|
◎ Target | Mike Hickey ★★★☆☆ #2021 | Buy | $21.00→ $22.00+4.8% |
|
Aug 07
18:34 UTC
|
ONT
Montrose Environmental Group
|
◎ Target | James Ricchiuti ★★★★☆ #853 | Buy | $28.00→ $23.00-17.9% |
|
Aug 07
18:34 UTC
|
NRXP
NRx Pharmaceuticals
|
◎ Target | Thomas Shrader ★★☆☆☆ #2543 | Buy | $25.00→ $10.00-60.0% |
|
Aug 07
18:34 UTC
|
NET
Cloudflare
|
◎ Target | James Fish ★★★★★ #102 | Overweight | $250.00→ $333.00+33.2% |
|
Aug 07
18:34 UTC
|
LOCO
El Pollo Loco
|
◎ Target | Todd Brooks ★★★☆☆ #1111 | Buy | $18.00→ $21.00+16.7% |
|
Aug 07
18:34 UTC
|
JANX
Janux Therapeutics
|
◎ Target | Brad Canino not yet tracked | Buy | $58.00→ $55.00-5.2% |
|
Aug 07
18:34 UTC
|
INSM
Insmed
|
◎ Target | Vamil Divan ★★★★☆ #374 | Buy | $207.00→ $205.00-1.0% |
|
Aug 07
18:34 UTC
|
GLUE
Monte Rosa Therapeutics
|
◎ Target | Michael Schmidt ★★★☆☆ #1614 | Buy | $35.00→ $28.00-20.0% |
|
Aug 07
18:34 UTC
|
GHRS
GH Research
|
◎ Target | Eddie Hickman ★★★★★ #289 | Buy | $34.00→ $40.00+17.6% |
|
Aug 07
18:34 UTC
|
FTDR
Frontdoor
|
◎ Target | Michael Rindos ★★★☆☆ #1214 | Buy | $80.00→ $96.00+20.0% |
|
Aug 07
18:34 UTC
|
FROG
JFrog
|
◎ Target | Yi Fu Lee ★★★☆☆ #1275 | Buy | $100.00→ $120.00+20.0% |
|
Aug 07
18:34 UTC
|
FIVN
Five9
|
◎ Target | James Fish ★★★★★ #102 | Neutral | $24.00→ $30.00+25.0% |
|
Aug 07
18:34 UTC
|
FISV
Fiserv
|
◎ Target | Tien-Tsin Huang not yet tracked | Neutral | $62.00→ $60.00-3.2% |
|
Aug 07
18:34 UTC
|
ETSY
Etsy
|
◎ Target | Steven Forbes ★★★☆☆ #1030 | Buy | $85.00→ $95.00+11.8% |
|
Aug 07
18:34 UTC
|
EPAM
EPAM Systems
|
◎ Target | Puneet Jain ★★★☆☆ #2096 | Overweight | $142.00→ $120.00-15.5% |
|
Aug 07
18:34 UTC
|
DKNG
DraftKings
|
◎ Target | Mike Hickey ★★★☆☆ #2021 | Buy | $29.00→ $30.00+3.4% |
|
Aug 07
18:34 UTC
|
CXW
CoreCivic
|
◎ Target | Bill Sutherland ★★★☆☆ #1181 | Buy | $41.00→ $45.00+9.8% |
|
Aug 07
18:34 UTC
|
CIFR
Cipher Mining
|
◎ Target | Richard Choe ★★★☆☆ #2092 | Overweight | $23.00→ $22.00-4.3% |
|
Aug 07
18:34 UTC
|
CELH
Celsius
|
◎ Target | Andrea Teixeira not yet tracked | Overweight | $56.00→ $52.00-7.1% |
|
Aug 07
18:34 UTC
|
CART
Maplebear
|
◎ Target | Mark Zgutowicz ★★★☆☆ #1862 | Buy | $55.00→ $63.00+14.5% |
|
Aug 07
18:34 UTC
|
ARLO
Arlo Technologies
|
◎ Target | James Fish ★★★★★ #102 | Overweight | $17.00→ $18.00+5.9% |
|
Aug 07
18:34 UTC
|
AKAM
Akamai Technologies
|
◎ Target | James Fish ★★★★★ #102 | Neutral | $156.00→ $140.00-10.3% |
|
Aug 07
18:34 UTC
|
ABNB
Airbnb
|
◎ Target | Thomas Champion ★★★☆☆ #1930 | Neutral | $145.00→ $170.00+17.2% |
|
Aug 07
18:34 UTC
|
ABNB
Airbnb
|
◎ Target | Daniel L. Kurnos not yet tracked | Buy | $160.00→ $180.00+12.5% |
|
Aug 07
18:34 UTC
|
CELH
Celsius
|
↓ Downgrade | Cristian Rios not yet tracked | Outperform→ Market Perform | $44.00→ $26.00-40.9% |
|
Aug 07
18:34 UTC
|
VRT
Vertiv
|
↑ Upgrade | Gordon L. Johnson not yet tracked | Hold→ Buy | $381.00 |
|
Aug 07
18:34 UTC
|
U
Unity Software
|
↑ Upgrade | Mike Hickey ★★★☆☆ #2021 | Hold→ Buy | $50.00 |
|
Aug 07
17:34 UTC
|
ZVRA
Zevra Therapeutics
|
◎ Target | Eddie Hickman ★★★★★ #289 | Buy | $24.00→ $23.00-4.2% |
|
Aug 07
17:34 UTC
|
XYZ
Block
|
◎ Target | Stephen Biggar ★★★★★ #156 | Buy | $86.00→ $103.00+19.8% |
|
Aug 07
17:34 UTC
|
VCTR
Victory Capital
|
◎ Target | Michael Cho ★★★☆☆ #1267 | Neutral | $87.00→ $101.00+16.1% |
|
Aug 07
17:34 UTC
|
USFD
US Foods
|
◎ Target | John Heinbockel ★★☆☆☆ #2551 | Buy | $115.00→ $120.00+4.3% |
|
Aug 07
17:34 UTC
|
TGTX
TG Therapeutics
|
◎ Target | Brian Cheng ★★★☆☆ #1735 | Overweight | $65.00→ $72.00+10.8% |
|
Aug 07
17:34 UTC
|
TGT
Target
|
◎ Target | Christopher Horvers ★★★★☆ #536 | Neutral | $129.00→ $157.00+21.7% |
|
Aug 07
17:34 UTC
|
TEAM
Atlassian
|
◎ Target | Howard Ma ★★★★★ #27 | Buy | $115.00→ $165.00+43.5% |
|
Aug 07
17:34 UTC
|
TAP
Molson Coors Beverage
|
◎ Target | Michael Lavery ★★★☆☆ #1746 | Neutral | $45.00→ $44.00-2.2% |
|
Aug 07
17:34 UTC
|
SVV
Savers Value Village
|
◎ Target | Peter Keith ★★★☆☆ #961 | Neutral | $10.00→ $11.00+10.0% |
|
Aug 07
17:34 UTC
|
SVV
Savers Value Village
|
◎ Target | Matthew Boss ★★★☆☆ #1370 | Neutral | $11.00→ $14.00+27.3% |
|
Aug 07
17:34 UTC
|
SHC
Sotera Health
|
◎ Target | Casey Woodring ★★★★★ #53 | Neutral | $16.00→ $18.00+12.5% |
|
Aug 07
17:34 UTC
|
RYTM
Rhythm Pharmaceuticals
|
◎ Target | Priyanka Grover not yet tracked | Overweight | $145.00→ $146.00+0.7% |
|
Aug 07
17:34 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Chris Schott ★★★☆☆ #958 | Overweight | $58.00→ $62.00+6.9% |
|
Aug 07
17:34 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yatin Suneja ★★★☆☆ #1773 | Buy | $36.00→ $42.00+16.7% |
|
Aug 07
17:34 UTC
|
RMD
ResMed
|
◎ Target | Adam Maeder ★★★☆☆ #2073 | Neutral | $233.00→ $225.00-3.4% |
|
Aug 07
17:34 UTC
|
REPL
Replimune Group
|
◎ Target | Anupam Rama ★★☆☆☆ #2753 | Overweight | $17.00→ $20.00+17.6% |
|
Aug 07
17:34 UTC
|
QSR
Restaurant Brands International
|
◎ Target | Brian Mullan ★★★☆☆ #1950 | Overweight | $85.00→ $81.00-4.7% |
|
Aug 07
17:34 UTC
|
QGEN
Qiagen
|
◎ Target | Casey Woodring ★★★★★ #53 | Overweight | $45.00→ $50.00+11.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.